Cardlytics Shareholders Approve Reverse Stock Split and Board Appointments

Key Facts

Cardlytics shareholders have officially approved a proposal authorizing a reverse split of the company's common stock during the recent annual meeting. The assembly also resulted in the election of three Class II directors and the ratification of Deloitte & Touche as the firm's independent auditors for the upcoming fiscal period.

These corporate actions arrive as Cardlytics navigates financial headwinds and technical price weakness. Reverse splits are frequently utilized by companies to boost share prices to meet exchange listing requirements and attract institutional interest. Per market data, the move highlights management's focus on stabilizing the capital structure relative to ad-tech industry peers.

Traders are monitoring CDLX price action for stability following the authorization, as the specific ratio and timing of the split remain at the board's discretion. Market participants are also looking ahead to the U.S. Retail Sales data on May 14, 2026, which could serve as a broader catalyst for consumer-exposed technology stocks.